Healthcare / Medical Care FacilitiesNasdaqGS
$19.94
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $38.1M · quality 34.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
24/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.4B
P/E
N/A
•EV/EBITDA
N/A
•ROE
11.6%
↑Gross Margin
N/A
•Debt/Equity
N/A
•Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2008–2025 · 17 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
+14.0%
FCF margin
7.6%
FCF / Net income
2.36x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.84B · net income $59.1M · FCF $139.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | $1.84B | $1.84B | $1.72B | $1.67B | $1.69B | $1.64B | $1.76B | $1.84B | $2.00B | $1.86B | — | — | — | — | — | — | — | — | — |
| Net Income | $59.1M | $59.1M | $39.5M | $38.4M | $34.2M | $48.5M | $98.7M | $64.6M | $83.5M | $88.2M | $77.4M | $58.0M | $21.9M | $47.1M | $44.2M | $38.2M | $34.4M | $30.3M | $26.6M |
| EPS | 0.81 | 0.81 | 0.53 | 0.52 | 0.46 | 0.65 | 1.32 | 0.87 | 1.12 | 1.19 | 1.05 | 0.80 | 0.31 | 0.67 | 0.65 | 0.56 | 0.51 | 0.46 | 0.40 |
| Net Margin | 3.2% | 3.2% | 2.3% | 2.3% | 2.0% | 3.0% | 5.6% | 3.5% | 4.2% | 4.7% | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||||
| Free Cash Flow | $139.2M | $139.2M | $24.5M | $38.1M | $-13.4M | $31.4M | $212.9M | $89.2M | $75.1M | $2.2M | $36.0M | $58.4M | $51.9M | $28.4M | $56.9M | $27.4M | $33.6M | $36.2M | $15.1M |
| Returns | |||||||||||||||||||
| ROE | 11.6% | 11.6% | 7.9% | 8.4% | 8.2% | 10.9% | 21.0% | 14.0% | 18.9% | 22.1% | 22.8% | 19.6% | 7.9% | 16.5% | 19.3% | 17.5% | 16.2% | 14.5% | 13.2% |
| Growth & Yield | |||||||||||||||||||
| Revenue Growth | 7.1% | 7.1% | 2.7% | -1.1% | 2.9% | -6.7% | -4.4% | -8.1% | 7.6% | — | — | — | — | — | — | — | — | — | — |
| EPS Growth | 52.8% | 52.8% | 1.9% | 13.0% | -29.2% | -50.8% | 51.7% | -22.3% | -5.9% | 13.3% | 31.3% | 158.1% | -53.7% | 3.1% | 16.1% | 9.8% | 10.9% | 15.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
3Y implied EPS CAGR
29.8%
EPS terminal req.
$1.77
Spread vs growth
23.1%
5Y implied EPS CAGR
21.5%
EPS terminal req.
$2.14
Spread vs growth
31.4%
10Y implied EPS CAGR
15.6%
EPS terminal req.
$3.45
Spread vs growth
37.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.